Business
AstraZeneca said to look at adapting COVID vaccine against blood clot risk – Sydney Morning Herald
AstraZeneca and scientists from the University of Oxford are looking at whether their COVID-19 vaccine can be modified to prevent…
AstraZeneca and scientists from the University of Oxford are looking at whether their COVID-19 vaccine can be modified to prevent rare blood clots, according to a person with knowledge of the situation.
The scientists are doing early-stage research on whether…
Continue Reading
-
Noosa News16 hours agoSuncorp Stadium upgrades to rival Sydney as seat capacity and infrastructure prioritised
-
Business19 hours agoWhy you should sell CBA, Lynas, and Tabcorp shares today
-
Business18 hours agoDroneShield announces new $13 million counter-drone facility as employees top 400
-
General18 hours agoDay of pain: sirens ring out to mark attack on Israel